A randomized controlled trial of Bi min fang granules and traditional Chinese medicine decoction in the treatment of persistent allergic rhinitis

Not Applicable

• Conditions: allergic rhinitis(AR)

• Registration Number: ITMCTR2200006157
• Lead Sponsor: Guangdong Provincial Hospital of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

? Subjects who meet the Chinese and Western diagnostic criteria for AR, those with Chinese medicine syndrome differentiation of Lung and Sleen deficiency, and those who meet the criteria for persistent allergic rhinitis (symptom onset = 4 days/week, and = 4 consecutive weeks).
? 18-65 years old, no gender limited.
? Subjects need informed consent, voluntarily accept the treatment according to the research allocation plan, basically can adhere to the treatment and follow-up plan, and have good compliance.
? Subjects are able to complete relevant records such as case report form as required.

Exclusion Criteria

? Patients who do not accept the contents of this trial.
? Patients combined with severe cardiovascular and cerebrovascular diseases, immunodeficiency, mental disorders or abnormal liver and kidney function and malignant tumors.
? For women who are pregnant or breastfeeding, if pregnancy is found during the trentment period, the test will be suspended.
? Patients who are easily lost to follow-up due to frequent changes in the work environment.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
total nasal symptom score, TNSS;

Secondary Outcome Measures

Name	Time	Method
the standardize dversion of the Rhinoconjunctivitis Quality of Life Questionnaire,RQLQ(S);eye symptom score;Rhinitis Control Assessment Test,RCAT;Use of anti-allergy medication scores;